KDNY Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own KDNY shares is N/A, representing N/A of the company's common stock.

FRANKLIN RESOURCES INC, in the last quarter, reduced its stake in KDNY by -1.33% restricting it's holding to 1.29 million shares of worth nearly $49.74M. FEDERATED HERMES, INC. also lessened -1.58% of the KDNY shares from its portfolio, reducing its holding to 1.23 million shares of worth $47.35M. LAURION CAPITAL MANAGEMENT LP also shunned KDNY shares holding by -0.65% last quarter which brought its holding to 824.38 thousand shares worth $31.67M.

As per its latest 13F filing, MAGNETAR FINANCIAL LLC increased its stake in KDNY by 100% in the last quarter. The institutional holder raised its holding to 1.26 million shares having worth more than $48.49M. GEODE CAPITAL MANAGEMENT, LLC also added 11.79% more shares of KDNY to its portfolio, raising its holding to 1.06 million shares of worth $40.74M. BIOIMPACT CAPITAL LLC also increased its KDNY shares holding by 407.27% which brought its holding to 1 million shares worth $38.55M.

The insider with the most stakes in KDNY is AKKARAJU SRINIVAS , at the company. Additionally, KDNY stock is highly held by 10 percent owner Versant Venture Capital VII, L.P. and director Jerel Davis among others.

Company executives, directors, and other insiders own N/A percent of Chinook Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which KDNY insiders have sold stock, totaling 0 shares. Insiders that have sold shares include KING ANDREW JAMES, GREENMAN WILLIAM MARINER, and DOBMEIER ERIC.

There have been 0 transaction(s) during the past 6-months in which Chinook Therapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Chinook Therapeutics, Inc. shares are held by insiders, which represents about N/A of KDNY stock.

KDNY , AKKARAJU SRINIVAS holds the largest portfolio of the company's shares. KDNY shares owned by AKKARAJU total nearly 5.16 million.

FRANKLIN RESOURCES INC is the largest institutional owner in KDNY which holds 1.29 million shares worth $49.74M or 1.81% of the total KDNY shares outstanding followed by MAGNETAR FINANCIAL LLC with ownership of 1.26 million shares representing 1.76% of the KDNY ownership. FEDERATED HERMES, INC. is the third largest stakeholder with 1.23 million shares or 1.74% of the ownership worth more than $47.35M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the KDNY is concerned, it is a stock which is optionable.

Number of KDNY shares short is N/A. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, N/A shares of KDNY are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, KDNY has N/A shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for KDNY is N/A.